US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Momentum Metropolitan Holdings Ltd (PK) (MMTHF) 銘柄情報

Momentum Metropolitan Holdings Ltd (PK) (MMTHF)

2.15

0.00

(0.00%)

終了 6月9日 5:00AM

Momentum Metropolitan Holdings Ltd (PK) (MMTHF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

2.15

( - )

買値

0.4592

売値

902.28

出来高

-

0.00 日の範囲 0.00

0.70 52 週間の範囲 2.15

時価総額

前日終値

2.15

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 2,335,379

発行済株式数

1,277,644,371

配当利回り

2 (5.99%)

PER

8.15

1 株当たり利益 (EPS)

4.47

歳入

63.23B

純利益

6.03B

Momentum Group Limited, together with its subsidiaries, provides insurance and financial services in South Africa and internationally. It operates through Momentum Retail, Momentum Investments, Metropolitan Life, Momentum Corporate, Momentum Metropolitan Health, Guardrisk, Momentum Insure, Momentum ... Momentum Group Limited, together with its subsidiaries, provides insurance and financial services in South Africa and internationally. It operates through Momentum Retail, Momentum Investments, Metropolitan Life, Momentum Corporate, Momentum Metropolitan Health, Guardrisk, Momentum Insure, Momentum Metropolitan Africa, India, and Shareholders segments. The company offers long and short-term insurance; employee benefits; asset management, property management, investments, and savings; health administration services, such as managed care and wellness services. It also provides insurance products, such as life, non-life, health, and annuities and structured products. The company operates under the Metropolitan, Momentum, Guardrisk, Eris, and other brands. The company was formerly known as Momentum Metropolitan Holdings Limited. Momentum Group Limited is headquartered in Centurion, South Africa. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.momentumgroupltd.co.za

本社

Centurion, South Africa

設立

-

Momentum Metropolitan Holdings Ltd (PK) is listed in the sector of the その他OTC with ticker MMTHF. The last closing price for Momentum Metropolitan (PK) was US$2.15. Over the last year, Momentum Metropolitan (PK) shares have traded in a share price range of US$ 0.70 to US$ 2.15.

Momentum Metropolitan (PK) currently has 1,277,644,371 shares in issue. The market capitalisation of Momentum Metropolitan (PK) is US$2.75 billion. Momentum Metropolitan (PK) has a price to earnings ratio (PE ratio) of 8.15.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	2.15	2.15	2.15	10472	2.15	CS
4	0	0	2.15	2.15	2.15	10472	2.15	CS
12	1.45	207.142857143	0.7	2.15	0.7	2618	2.15	CS
26	1.45	207.142857143	0.7	2.15	0.7	1309	2.15	CS
52	1.45	207.142857143	0.7	2.15	0.7	551	2.15	CS
156	1.45	207.142857143	0.7	2.15	0.7	480	2.07677033	CS
260	1.45	207.142857143	0.7	2.15	0.7	480	2.07677033	CS

MMTHF - Frequently Asked Questions (FAQ)

What is the current Momentum Metropolitan Holdings Ltd (PK) share price?

The current share price of Momentum Metropolitan Holdings Ltd (PK) is US$ 2.15

How many Momentum Metropolitan Holdings Ltd (PK) shares are in issue?

Momentum Metropolitan Holdings Ltd (PK) has 1,277,644,371 shares in issue

What is the market cap of Momentum Metropolitan Holdings Ltd (PK)?

The market capitalisation of Momentum Metropolitan Holdings Ltd (PK) is USD 2.75B

What is the 1 year trading range for Momentum Metropolitan Holdings Ltd (PK) share price?

Momentum Metropolitan Holdings Ltd (PK) has traded in the range of US$ 0.70 to US$ 2.15 during the past year

What is the PE ratio of Momentum Metropolitan Holdings Ltd (PK)?

The price to earnings ratio of Momentum Metropolitan Holdings Ltd (PK) is 8.15

What is the cash to sales ratio of Momentum Metropolitan Holdings Ltd (PK)?

The cash to sales ratio of Momentum Metropolitan Holdings Ltd (PK) is 0.74

What is the registered address of Momentum Metropolitan Holdings Ltd (PK)?

The registered address for Momentum Metropolitan Holdings Ltd (PK) is 268 West Avenue, Centurion, Gauteng, 0157

What is the Momentum Metropolitan Holdings Ltd (PK) website address?

The website address for Momentum Metropolitan Holdings Ltd (PK) is www.momentumgroupltd.co.za

PurpleCritter2001

PurpleCritter2001 4分前

You were a Photonics Engnieer at Intel for 35 years?

HyGro

Actually READ FDA ECA Guidelines:

"Sponsors should finalize a study protocol before initiating the externally controlled trial, including selection of the external control arm and analytic approach, rather than selecting an external control arm after the completion of a single-arm tri

rogers711

rogers711 6分前

Achilles deFlandres

Achilles deFlandres 6分前

Elephant in the room. After the "blah blah...blah" is over the speeding wheels of the bureaucracy will make this a many months process during which any number of events could derail it. Unfortunately the next president probably won't even discuss these things.

Zardiw

Remember the USS Liberty:

Attacked by israel:

https://www.youtube.com/watch?v=OqmoiUO4UDo

Z

Zardiw

Remember the USS Liberty:

Attacked by israel:

https://www.youtube.com/watch?v=OqmoiUO4UDo

Z

Dough Theory

Dough Theory 12分前

If a person doesn't like a stock, that's fine, then move on.
Why keep posting and show your immaturity? Who are they trying to impress?

Olle15

Olle15 13分前

The stock goes down every day..
More and more.
And the 47. Rates go down every
Day .
He must do it NOW!!!
Not bla bla bla...

flipper44

flipper44 15分前

Dr. Kalinski is the sponsor, NWBO is one of the collaborators.

Dabeav

Dabeav 17分前

Are you really letting a keyboard warrior getting under your skin, come on buddy! There is nothing anybody says on this sht show forum that means 2 fks to anyone. Don’t let this hub get to you bro. This whole hub is a sht show

Kool Aid Man

Kool Aid Man 17分前

Al-Than's bloated resume'--- Prior to his current role (with Ameerex), he served as the Assistant CEO of Qatar General Group (a major Qatari insurance and investment conglomerate) from 2015 until 2020, where he honed his expertise in managing massive multi-billion-Riyal investment portfolios . Yeah

Boston-Bets

Boston-Bets 17分前

"It is being 'shorted' so *Insiders* can 'scoop up' the Cheap shares OR are you saying we could expect these shares will be given to "WamU Escrow-holders for our Assets? "

NEITHER. The theory goes that there's apparently 100's of Millions of Class-L shares that are going to be convert

BDEZ

https://x.com/PikachOTC/status/2062848269726728334

ENZC

rogers711

rogers711 18分前

The stock price after submittal says it all. Little to no one cares about this anymore in my opinion.

Loungerr

Loungerr 19分前

I do have trading shares in Ira.though.never sold in other acct.

Slojab

Slojab 21分前

We've been trading in a channel the past three months. And we traded within that channel today. I was hoping the latest news would push us past $.01.

News of returning shares to the Treasury would do it, I bet.

biosectinvestor

biosectinvestor 23分前

The flaw in your argument is a class/category error.

You are applying a tissue-agnostic biomarker framework developed for a specific new class of oncology drugs — molecularly targeted therapies — to a different new class of treatment: dendritic-cell immunotherapy.

Those

splintered sunlight

splintered sunlight 25分前

More specific.

Sure.

Quick question.

When the FDA turned down RDGL's submission in August 2025, was it an EFS IDE submission or an IDE submission?

EarningsCentral

EarningsCentral 28分前

AKATITUS

AKATITUS 29分前

Tomorrow
Should
Be
Interesting

Alley-oop

Alley-oop 30分前

Even though the stock price is not going as expected

NY1972

NY1972 32分前

Single large dose CART is not going to work. Kimmtrak is like a weekly low dose CART

Loungerr

Loungerr 33分前

I’ve always been long and never sold a share but when I said was short ya all said at least your telling the truth.My first buy was a year ago at.98.truth

Juststoppingby

Juststoppingby 33分前

Some of those 10 million shares that convert to 200+some cheers were also for some of the Coretec old management/board members. I have to look back; it's been almost two years.
When they file, we will know exactly who gets what.
If they want to uplist to NASDAQ, they aren't going to co

CatfishHunter

CatfishHunter 34分前

Be more specific, as they waisted few years at the beginning trying for DeNovo when they should have known FDA would never giveClass 2 designation to Radiogel. After that, it has always been EFS IDE. Just the earlier EFS submissions were MK doing it on his own. This current EFS IDE is with a John

Momentum Metropolitan (PK)

HSBC MSCI Emerging Marke...

Transcontinental

Daiwa Asset Management

Wineco Prod (EM)

L&G ETFS Battery Value-C...

WisdomTree Gold 3x Daily...

Regeneron Pharmaceuticals

DJ Global exUS Consumer ...

Accendra Health

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。